To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is a multicentre, randomised, double-blind, placebo-controlled, 4-way cross-over study.
At each study visit a standardised treadmill test will be performed to provoke EIA. Before
and after the challenge test pulmonary function variables (e.g. forced expiratory volume in
one second (FEV1)) will be measured in order to assess the protective effect of the study
medication.